Page 336 - Read Online

Lancaster et al. Vessel Plus 2019;3:34 I http://dx.doi.org/10.20517/2574-1209.2019.16 Page 7 of 8

14. Thai HM, Juneman E, Lancaster JJ, Do R, Castellano L, et al. Implantation of a three-dimensional fibroblast matric improves left
ventricular function and blood flow after acute myocardial infarction. Cell Transplant 2009;18:283-95.
15. Lancaster JJ, Juneman E, Hagerty T, Do R, Hicks M, et al. Viable fibroblast matric patch induces angiogenesis and increases
myocardial blood flow in heart failure after myocardial infarction. Tissue Eng Pt A 2010;16:3065-73.
16. Lancaster JJ, Arne SA, Johnson NM, Qin Y, Witte R, et al. An electrically coupled tissue-engineered cardiomyocyte scaffold improves
cardiac function in rats with chronic heart failure. J Heart Lung Transplant 2014;33:438-45.
17. Gao L, Kupfer ME, Jung JP, Yang L, Zhang P, et al. Myocardial Tissue Engineering With Cells Derived From Human-Induced
Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold. Circ Res 2017;120:1318-25.
18. Wnorowski A, Wu JC. 3-Dimensionally Printed, Native-Like Scaffolds for Myocardial Tissue Engineering. Circ Res 2017;120:1224-6.
19. Menasché P, Vanneaux V, Hagège A, Bel A, Cholley B, et al. Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular
Progenitors for Severe Ischemic Left Ventricular Dysfunction. J Am Coll Cardiol 2018;71:429-38.
20. Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, et al. Feasibility, safety, and therapeutic efficacy of human induced
pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 2012;126:S29-37.
21. Schmuck EG, Mulligan JD, Ertel RL, Kouris NA, Ogle BM, et al. Cardiac fibroblast-derived 3D extracellular matrix seeded with
mesenchymal stem cells as a novel device to transfer cells to the ischemic myocardium. Cardiovasc Eng Technol 2014;5:119-31.
22. Ruan JL, Tulloch NL, Razumova MV, Saiget VM, Pabon L, et al. Mechanical Stress Conditioning and Electrical Stimulation Promote
Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue. Circulation 2016;134:1557-67.
23. Zhang J, Zhu W, Radisic M, Vunjak-Novakovic G. Can we engineer a human cardiac patch for therapy? Circ Res 2018;123:244-65.
24. Akst J. Available from:https://www.the-scientist.com/news-opinion/donor-derived-ips-cells-show-promise-for-treating-eye-
disease-65817#.XMmiehFIHDk.email. [Last accessed on 2 Sep 2019].
25. Fujita B, Zimmermann WH. Myocardial Tissue Engineering for Regenerative Applications. Curr Cardiol Rep 2017;19:78.
26. Pearl JI, Kean LS, Davis MM, Wu JC. Pluripotent stem cells: immune to the immune system? Sci Transl Med 2012;4:164ps25.
27. Cyranoski D. Reprogrammed stem cells approved to mend hearts Japanese study is only the second application of induced pluripotent
stem cells in people. Nature 2018;557:619-20.
28. Meissner T, Strominger J, Cowan C. The universal donor stem cell: removing the immune barrier to transplantation using CRISPR/
Cas9 (TRAN1P.946) J Immunol 2015;194:140.28.
29. Gershlaka JR, Hernandez S, Fontanac G, Perreaul LR, Hansen KJ, et al. Crossing kingdoms: Using decellularized plants as perfusable
tissue engineering scaffolds. Biomaterials 2017;125:13-22.
30. Liau B, Christoforou N, Leong KW, Bursac N. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and
function. Biomaterials 2011;32:9180-7.
31. Kim DH, Kshitiz NV, Smith RR, Kim P, Ahn EH, et al. Nanopatterned cardiac cell patches promote stem cell niche formation and
myocardial regeneration. Integr Biol-UK 2012;4:1019-33.
32. Jang J, Park HJ, Kim SW, Kim H, Park JY, et al. 3D printed complex tissue construct using stem cell-laden decellularized extracellular
matrix bioinks for cardiac repair. Biomaterials 2017;112:264-74.
33. Tsui JH, Ostrovsky-Snider NA, Yama DMP, Donohue JD, Choi JS, et al. Conductive silk-polypyrrole composite scaffolds with
bioinspired nanotopographic cues for cardiac tissue engineering. J Mater Chem B 2018;6:7185-96.
34. Machiraju P, Greenway SC. Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes .World J
Stem Cells 2019;11:33-43.
35. Lancaster OJ, Sanchez P, Repetti GG, Juneman E, Pandey AC, et al. Human Induced Pluripotent Stem Cell–Derived Cardiomyocyte
Patch in Rats With Heart Failure. Ann Thorac Surg 2019; doi: 10.1016/j.athoracsur.2019.03.099.
36. Wei K, Serpooshan V, Hurtado C. Diez-Cun˜ado M, Zhao M, et al. Epicardial FSTL1 reconstitution regenerates the adult mammalian
heart. Nature 2015:525;479-85.
37. Masters M, Riley PR. The epicardium signals the way towards heart regeneration. Stem Cell Res 2014;13:683-92.
38. Cao J, Poss KD. The epicardium as a hub for heart regeneration. Nat Rev Cardiol 2018;15:631-47.
39. Zimmermann WH, Melnychenko I, Wasmeier G, Didié M, Naito H, et al. Engineered heart tissue grafts improve systolic and diastolic
function in infarcted rat hearts. Nat Med 2006;12:452-8.
40. Matsubayashi K, Fedak PW, Mickle DA, Weisel RD, Ozawa T, et al. Improved left ventricular aneurysm repair with bioengineered
vascular smooth muscle grafts. Circulation 2003;108 Suppl 1:II219-25.
41. Sawa Y, Yoshikawa Y, Toda K, Fukushima S, Yamazaki K, et al. Safety and efficacy of autologous skeletal myoblast sheets (TCD-
51073) for the treatment of severe chronic heart failure due to ischemic heart disease. Circ J 2015;79:991-9.
42. Yoshikawa Y, Miyagawa S, Toda K, Saito A, Sakata Y, et al. Myocardial regenerative therapy using a scaffold-free skeletal-muscle-
derived cell sheet in patients with dilated cardiomyopathy even under a left ventricular assist device: a safety and feasibility study.
Surg Today 2018;48:200-10.
43. Yorgan K, Brenière-Letuffe D, Mannhardt I, Schulze T, Ulmer B, et al. Differentiation of cardiomyocytes and generation of human
engineered heart tissue. Nat Protoc 2017;12:1177-97.
44. Liu J, Hu Q, Wang Z, Xu C, Wang X, et al. Autologous stem cell transplantation for myocardial repair. Am J Physiol Heart Circ
Physiol 2004;287:H501-11.
45. Godier-Furnemont AF, Martens TP, Koeckert MS, Wan L, Parks J, et al. Composite scaffold provides a cell delivery platform for
cardiovascular repair. Proc Natl Acad Sci USA 2011;108:7974-9.
46. Matsuura K, Wada M, Shimizu T, Haraguchi Y, Sato F, et al. Creation of human cardiac cell sheets using pluripotent stem cells.